First Tracks Financials - Benzinga

First Tracks Biotherapeutics Inc

TRAXNASDAQ

Trade with Public

Trade with Public

$40.46

-2.05-4.82%

At close: Sep 4, 5:00 PM EST

$40.46

N/A

After Hours: Sep 4, 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

First Tracks Financials

First Tracks (TRAX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.

Avi Kapoor

PRO
First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY

First Tracks (NASDAQ:TRAX) reported quarterly losses of $(0.95) per share. This is a 35.37 percent increase over losses of $(1.47) per share from the same period last year.

Benzinga Newsdesk